SOURCES SOUGHT SYNOPSIS
THIS REQUEST FOR INFORMATION (RFI) IS ISSUED SOLELY FOR INFORMATION AND PLANNING PURPOSES ONLY AND DOES NOT CONSTITUTE A SOLICITATION. THE SUBMISSION OF PRICING, CAPABILITIES FOR PLANNING PURPOSES, AND OTHER MARKET INFORMATION IS HIGHLY ENCOURAGED AND ALLOWED UNDER THIS RFI IN ACCORDANCE WITH (IAW) FAR 15.201 (e).
The purpose of this Request for Information (RFI) is to gain knowledge of potential qualified sources and their size classification (hubzone, 8(a), small, small disadvantage, veteran owned small business (VOSB), service disabled veteran owned small business (SDVOSB), or large business) relative to NAICS 325413, 1,250 size standard number of employees.Ã‚Â Note that if VA s pending market research establishes that two or more VOSB or SDVOSB, who are certified in VA s Vendor Information Pages (VIP) site https://www.vip.vetbiz.gov/ eligible and capable, VA will set aside the underlying solicitation per 38 U.S.C. Ã‚Â§8127.Ã‚Â
Responses to this RFI will be used by the Government to make appropriate acquisition decisions to fulfill this requirement. After review of all responses to this RFI, a solicitation announcement may be published on FBO and/or GSA eBuy. Response to this RFI are not considered adequate responses to a solicitation announcement. Responses to this notice are not offers and cannot be accepted by the Government to form a binding contract.
PARTICIPATING HEALTHCARE FACILITY:
VA Greater Los Angeles Healthcare System
11301 Wilshire Blvd
Los Angeles, CA 90073
The Department of Veterans Affairs (VA), Network Contracting Office 22, VHA Regional Procurement Office – West, has a requirement to establish a procurement for detection kit used for Genotyping. The requirement is HLA-B*5801 gene test kit, related to medication called Allopurinol. The HLA-B*5801 gene test will be used to identify those at risk for serious side effects, hypersensitivity and adverse reactions to medication Allopurinol treatment.
Vendor Product Number
PG5801 Detection Kit (RUO)
48 reactions (20 samples)/box
Brand name information: Pharmigene, Inc.
Notice: Remanufactures or gray market items/ supplies will not be acceptable. Interested parties must be an authorized reseller, distributor, or dealer of the O.E.M. (Original Equipment Manufacturer). Verification can be provided by an authorization letter or other documents from the OEM. Equipment shall be in accordance with the OEM terms and conditions. No exceptions, must be a manufacturer authorized distributor.
Additional information for this requirement will be provided on a later solicitation. A solicitation is not currently available. Response to this RFI will help the Government make appropriate acquisition decisions to fulfill this requirement.
In response to this announcement, please complete the information below:
Business size information
Select all that applies:
Emerging Small Business
Small Disadvantaged Business
Certified under Section 8(a) of the Small Business Act
Certified Service-Disabled Veteran Owned Small in Vetbiz.gov
Certified Veteran Owned Small Business in Vetbiz.gov
Please answer the following questions:
FSS/ GSA Contract Holder
FSS/ GSA Contract Number
Effective Date / Expiration Date
Is your company considered small under the NAICS code 325413?
Are you authorized distributor? If yes, please provide proof.
This notice is not a request for competitive proposal or solicitation of offerors. This notice is to assist the VA in determining sources only and a solicitation is not currently available. If a solicitation is issued it will be later published on FBO and/or GSA eBuy. Interested parties must respond to later solicitation announcement separately from this source sought. Response to this source sought is not a request to be added to a prospective bidders list or to receive a copy of the later solicitation. Information received as a result of this notice will be considered solely for the purpose to make appropriate acquisition decisions to fulfill this requirement. This notice does not represent a commitment by the Government to pay for costs incurred in the preparation and submission of information or any other costs incurred as a response to this announcement. Please reference Source Sought Notice 36C26220Q1249 for inquiries. Inquiries will only be accepted in writing via email to Anthony.DelaCruz@va.gov before Friday August 7, 2020 by 4:30 PM PST.
We appreciate your interest in fulfilling VA Greater Los Angeles Healthcare System requirement of HLA-B*5801 gene test kit, related to medication Allopurinol. Have a great day. Thank you.
Anthony Dela Cruz